ADP-ribosylation factor (ARF) 6 has been shown to play a role in vesicular transport; however, the expression and subcellular localization of the endogenous protein have not been clearly delineated. In this study, an ARF6-specific monoclonal antibody was raised and used to examine the subcellular distribution and expression of ARF6 in various tissues and during the differentiation of several well characterized cell types. We found that ARF6 localizes in both the cytosol and membranes of all tissues and cells tested. Moreover, ARF6 in 3T3-L1 adipocytes is principally localized on the plasma membrane, but substantial amounts are detected in the cytosolic and intracellular membrane fractions. We observed an increased expression of ARF6 during the differentiation of B lymphocytes to plasmocytes. However, the expression of ARF6 decreased during adipogenesis and monocyte differentiation. In contrast, the expression of other ARFs, detected by the monoclonal antibody 1D9, did not significantly change during differentiation of the aforementioned cell types. Taken together, our results indicate that ARF6 is a broadly expressed, differentially regulated GTPase that is present in cytoplasm and on both cell-surface and intracellular membranes and whose functions may include tissuespecific effects on vesicular trafficking during cellular differentiation.ADP-ribosylation factors are members of the Ras superfamily of low molecular weight GTP-binding proteins. Although ARFs 1 have been identified as cofactors required for the cholera toxin-catalyzed ADP-ribosylation of the heterotrimeric G protein G s (1), they have been shown to play an important role in membrane trafficking. Six mammalian ARF genes have been identified, of which five corresponding proteins have been found in humans. The most extensively studied is ARF1, which has been used, almost exclusively, to study the biology of ARFs. This protein appears to cycle between the cytosol and its membrane targets in the Golgi apparatus (2-4). ARF regulates membrane trafficking along the secretory pathway by facilitating coatomer binding to Golgi membranes and by maintaining the integrity of the Golgi complex (5, 6). ARFs also stimulate the activity of phospholipase D in vitro (7-9), suggesting that they may exert their effects at least in part by altering membrane phospholipid metabolism.ARF6 has been suggested to play a role in vesicle trafficking and cytoskeletal organization (10 -13). Overexpressed ARF6 is localized on the plasma membrane and endosomes, suggesting a role for this protein in membrane trafficking along the endocytic pathway (10, 11). However, a recent report suggested that endogenous ARF6 is exclusively localized on the plasma membrane in CHO cells (14). Others have found that ARF6 is localized on chromaffin granules, suggesting that it mediates exocytosis during regulated secretion (15).Based on the above results, it appears that ARF6 has a cell type-dependent subcellular distribution. To investigate this question further, we developed an ARF6 monoclonal ant...